A novel kinase inhibitor, Regorafenib, blocks EGFR-dependent signaling to repress tumour metastasis in human triple-negative breast cancers

Ludong Zhao(Jinzhou Medical University), Ying Liu(Jinzhou Medical University)
Frontiers in Cell and Developmental Biology
March 3, 2026
Cited by 0


Related Papers